IL6 and type 2 diabetes mellitus: Another meta-analysis, which included 16 trials and 706 patients with T2DM, demonstrated an increase in total antioxidant capacity and a decrease in inflammatory markers, such as CRP, IL-6, and TNF concentrations [56].